PRESS RELEASE published on 06/14/2024 at 11:46, 3 months 14 days ago Publication of Annual Report Novacyt S.A. announces the publication of its Annual Report for the year ended 31 December 2023. The report is available on the company's website Annual Report Euronext Growth Molecular Diagnostics Novacyt S.A. Integrated Technologies
BRIEF published on 06/04/2024 at 15:16, 3 months 24 days ago Novacyt General Meeting: Shareholder Vote Approaching Shareholders General Assembly Quorum Vote Novacyt
BRIEF published on 06/04/2024 at 15:15, 3 months 24 days ago Novacyt S.A. Announces AGM Voting Procedures Shareholders AGM Voting Molecular Diagnostics Novacyt
PRESS RELEASE published on 06/04/2024 at 15:10, 3 months 24 days ago AGM voting Novacyt S.A. announces AGM voting to be held online on 26 June 2024. Shareholders can vote in advance and access meeting details at www.novacyt.com/investors Shareholders AGM Voting Novacyt S.A. Online Meeting
BRIEF published on 06/03/2024 at 15:52, 3 months 25 days ago Novacyt: Monthly review of the liquidity contract and voting rights Liquidity Contract Actions INVEST SECURITIES Right To Vote Novacyt
BRIEF published on 05/20/2024 at 10:56, 4 months 9 days ago Novacyt announces the publication of its financial results and convenes its Annual General Meeting Financial Results Investors Webinar General Assembly Novacyt
BRIEF published on 05/20/2024 at 10:54, 4 months 9 days ago Novacyt Announces Financial Results and Annual General Meeting Financial Results AGM Molecular Diagnostics Investor Webinar Novacyt
PRESS RELEASE published on 05/20/2024 at 10:49, 4 months 9 days ago Notice of Results and Annual General Meeting Novacyt S.A. will report its audited financial results for the year ended 31 December 2023 on 30 May 2024 and hold its Annual General Meeting on 26 June 2024. An investor webinar is scheduled for 30 May 2024 Financial Results Annual General Meeting Molecular Diagnostics Investor Webinar Novacyt S.A.
Published on 09/28/2024 at 02:06, 1 day 9 hours ago Global Education Communities Corp. Reports Second Tranche Closing of Non-Brokered Private Placement
Published on 09/28/2024 at 02:00, 1 day 9 hours ago bettermoo(d)’s Moodrink(TM) Featured in Banners of Well-Known Canadian Retailers
Published on 09/28/2024 at 00:10, 1 day 11 hours ago LQWD Technologies Announces Non-Brokered Private Placement Update
Published on 09/28/2024 at 14:01, 21 hours 22 minutes ago Turkiye Garanti Bankasi A.S.: Explanation on Subordinated Debt Securities to Qualified Investors
Published on 09/27/2024 at 22:30, 1 day 12 hours ago DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update
Published on 09/27/2024 at 21:56, 1 day 13 hours ago EQS-Adhoc: FDA grants approval for Stelara® Biosimilar FYB202/OtulfiTM (ustekinumab-aauz)
Published on 09/27/2024 at 18:50, 1 day 16 hours ago PETROFAC ANNOUNCES IN-PRINCIPLE AGREEMENT ON FINANCIAL RESTRUCTURE
Published on 09/27/2024 at 18:40, 1 day 16 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/27/2024 at 17:45, 1 day 17 hours ago NFL BIOSCIENCES: 2024 FIRST-HALF BUSINESS AND EARNINGS UPDATE
Published on 09/26/2024 at 18:00, 2 days 17 hours ago GUILLEMOT CORPORATION: Availability of the interim financial report to June 30, 2024
Published on 09/26/2024 at 18:00, 2 days 17 hours ago GUILLEMOT CORPORATION: 2024 CONSOLIDATED INTERIM RESULTS
Published on 09/26/2024 at 17:47, 2 days 17 hours ago imerys-26-September-2024-information-share-capital-and-voting-rights-as-of-31-August-2024